Healthcare
Live Price
Offline$9.47
+2.16% today
1Y Change
+58.45%
Window
Jun 26, 2025 → Jun 16, 2026
Coverage: 244 bars · Jun 26, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Candel Therapeutics, Inc. (CADL) is a Healthcare stock with a market cap of $420.00M. The stock last traded around $9.47 and up 58.4% across the available one-year price window (Jun 26, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +58.6%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +58.6%, free cash flow -43.9% with operating margin 0.0% and ROIC -41.4%. Stock Foundry combines CADL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CADL
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CADL Max Drawdown
-37.04%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CADL and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.